+919405117673
Tamoxifen Tablets 10MG/20MG Import to UK from India
Tamoxifen Tablets 10MG and 20MG are an important prescription medicine used in the management of certain hormone-sensitive breast cancer conditions. Cordium Pharmaceuticals Pvt Ltd, based in India, supports international pharmaceutical supply and export requirements for Tamoxifen Tablets, subject to applicable regulations and documentation.

For UK buyers, pharmacies, licensed wholesalers, healthcare organizations and authorized pharmaceutical distributors looking for Tamoxifen 10MG/20MG from India, Cordium Pharma can assist with product information, commercial quotations and export documentation.

Tamoxifen Tablets 10MG/20MG Supplier from India to UK

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical products from India for international markets. Tamoxifen Tablets may be available in 10MG and 20MG strengths, depending on product availability and applicable market requirements.

UK importers should ensure that the importing party and product comply with current MHRA requirements, UK licensing requirements, customs procedures and applicable medicines legislation. UK rules can differ depending on whether the medicine is licensed, unlicensed, imported for wholesale distribution or intended for another permitted use.

Import Tamoxifen 10MG/20MG from India

Businesses seeking to import Tamoxifen Tablets from India should verify the required UK authorisations before placing an import order. For certain human medicines, UK importers may require appropriate wholesale or manufacturing/import licences, and additional requirements can apply to unlicensed medicines.

Cordium Pharma can support customers with relevant commercial and product documentation required for an international pharmaceutical transaction, according to the specific order and destination requirements.

Tamoxifen Tablets 10MG/20MG Export from India

India is an established pharmaceutical manufacturing and export market. Cordium Pharmaceuticals Pvt Ltd works with international buyers seeking pharmaceutical products from India.

Tamoxifen Tablets 10MG/20MG can be considered for supply to authorized UK pharmaceutical businesses, distributors and other eligible purchasers, subject to regulatory approval and import requirements.

Typical export documentation may include:

Commercial Invoice
Packing List
Product information
Batch and expiry details
Certificate of Analysis, where applicable
Shipping documentation
Other documents required by the importing authority or buyer
Tamoxifen 10MG/20MG UK Import Compliance

Before importing Tamoxifen into Great Britain, buyers should confirm whether the proposed product has the appropriate UK marketing authorisation or falls under an applicable unlicensed-medicine pathway. MHRA guidance states that importing unlicensed medicines can require notification and an appropriate UK licence, with the MHRA able to object to an import.

Therefore, Tamoxifen Tablets should not be promoted as freely importable into the UK without checking the applicable regulatory requirements.

Why Choose Cordium Pharmaceuticals Pvt Ltd?

Cordium Pharmaceuticals Pvt Ltd offers international pharmaceutical sourcing and export support from India. Buyers can contact the company for:

Tamoxifen Tablets 10MG/20MG availability
Export quotations from India
Product and batch information
Pharmaceutical documentation
Bulk enquiry support
International shipping coordination
UK-focused export documentation support
Tamoxifen Tablets 10MG/20MG – India to UK

If you are an authorized UK pharmaceutical importer, distributor, wholesaler or healthcare organization looking for Tamoxifen Tablets 10MG/20MG from India, contact Cordium Pharmaceuticals Pvt Ltd for current availability, pricing and export requirements.

Important: Tamoxifen is a prescription medicine. Product availability, importation, distribution and use must comply with the laws and regulatory requirements applicable in the UK and the importing organisation's jurisdiction. This page is intended for pharmaceutical trade information and does not replace advice from a qualified healthcare professional or regulatory authority.
Sep 14th, 2026 7:04 PM

Keywords